- Home
- TIL vs TVGN Comparison
TIL vs TVGN Comparison
Compare TIL & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TIL | TVGN |
|---|---|---|
| Founded | 2018 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.7M | 63.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | TIL | TVGN |
|---|---|---|
| Price | $7.09 | $0.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $125.00 | $5.00 |
| AVG Volume (30 Days) | 262.8K | ★ 751.1K |
| Earning Date | 03-03-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.67 | $0.28 |
| 52 Week High | $42.79 | $1.69 |
Technical Indicators
Market Signals| Indicator | TIL | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 32.88 | 37.20 |
| Support Level | $6.79 | $0.32 |
| Resistance Level | $7.32 | $0.35 |
| Average True Range (ATR) | 0.26 | 0.03 |
| MACD | 0.16 | -0.00 |
| Stochastic Oscillator | 48.87 | 18.01 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.